|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| C07D 403/14 | |||
| C07D 487/08 | |||
| C07D 487/10 | |||
| C07D 498/04 | |||
| C07D 471/04 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 3269715 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16761108.6 |
| Europos patento paraiškos padavimo data | 2016-03-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2016/076041 |
| Data | 2016-03-10 |
| (87) | Numeris | WO 2016/141881 |
| Data | 2016-09-15 |
| (30) | Numeris | Data | Šalis |
| 201510107436 | 2015-03-11 | CN | |
| 201610019047 | 2016-01-12 | CN |
| (72) |
DING, Charles Z., CN
CHEN, Shuhui, CN
ZHAO, Baoping, CN
XU, Zhaobing, CN
LIU, Yingchun, CN
LIN, Ruibin, CN
WANG, Fei, CN
LI, Jian, CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,
No. 369 Yuzhou South Road Haizhou District, Lianyungang, Jiangsu 222062,
CN
|
| (54) | SUBSTITUTED 2-HYDROGEN-PYRAZOLE DERIVATIVE SERVING AS ANTICANCER DRUG |
| SUBSTITUTED 2-HYDROGEN-PYRAZOLE DERIVATIVE SERVING AS ANTICANCER DRUG |